| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 66,694 | 90,228 | 90,321 | 192,169 | | Cost of Revenue | 67,749 | 85,466 | 89,515 | 194,795 | | | Gross Profit | (1,055) | 4,762 | 806 | (2,626) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 7,839 | 19,761 | 16,578 | 34,258 | | Non Recurring |
-
|
-
| 4,180 |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (8,894) | (14,999) | (19,952) | (36,884) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 27,110 |
-
|
-
|
-
| | Earnings Before Interest And Taxes | 18,216 | (14,999) | (19,952) | (36,884) | | Interest Expense | 29,065 | 1,019 | 1,864 | 741 | | Income Before Tax | (10,849) | (16,018) | (21,816) | (37,625) | | Income Tax Expense | 4,120 | (397) | 120 | (3,434) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (14,969) | (15,621) | (21,936) | (34,191) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| (37) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (14,969) | (15,621) | (21,936) | (34,228) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($14,969) | ($15,621) | ($21,936) | ($34,228) |
|
0.02% Nasdaq 
0.33%
Income Statement
